CHF129.00
4.03%
SIX Swiss Exchange, Sep 25, 05:31 pm CEST. Closed.
ISIN
CH0187624256
Symbol
VBSN

Ivf Hartmann Holding Stock price

CHF129.00
-1.00 0.77% 1M
-10.00 7.19% 6M
-14.00 9.79% YTD
-10.00 7.19% 1Y
+22.94 21.63% 3Y
-10.20 7.33% 5Y
-59.40 31.53% 10Y
+96.99 302.97% 20Y
SIX Swiss Exchange, Closing price Fri, Sep 25 2026
+5.00 4.03%
ISIN
CH0187624256
Symbol
VBSN

Is Ivf Hartmann Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.

Key metrics

Basic
Market capitalization
CHF294.5m
Enterprise Value
CHF187.0m
Net debt
positive
Cash
CHF108.2m
Shares outstanding
2.4m
Valuation (TTM | estimate)
P/E
15.2
P/S
1.7 | -
EV/Sales
1.1 | -
EV/FCF
8.1
P/B
1.9
Dividends
DPS
CHF3.80
Yield 1Y | 5Y
3.0% | 2.3%
Growth 1Y | 5Y
18.8% | 2.8%
Payout 1Y | 3Y
81.4% | 74.2%
Increased
4 Years
Financials (TTM | estimate)
Revenue
CHF170.4m | -
EBITDA
CHF28.6m
EBIT
CHF23.8m
Net Income
CHF20.3m
Free Cash Flow
CHF23.2m
Growth (TTM | estimate)
Revenue
6.9% | -
EBITDA
4.7%
EBIT
7.8%
Net Income
6.9%
Free Cash Flow
64.7%
Margin
Gross
54.3%
EBITDA
16.8%
EBIT
14.0%
Net
11.9%
Free Cash Flow
13.6%
Financial Health
Equity Ratio
79.3%
Return on Equity
11.8%
ROCE
14.8%
ROIC
32.2%
Debt/Equity
0.0
More
EPS
CHF8.5
FCF per Share
CHF9.7
Short interest
-
Employees
279
Rev per Employee
CHF580.0k

Financial data from Ivf Hartmann Holding

Jun '26
+/-
%
170 170
7% 7%
100%
- Direct Costs 78 78
10% 10%
46%
93 93
4% 4%
54%
- Selling and Administrative Expenses 32 32
5% 5%
19%
- Research and Development Expense - -
-
-
29 29
5% 5%
17%
- Depreciation and Amortization 4.76 4.76
8% 8%
3%
EBIT (Operating Income) EBIT 24 24
8% 8%
14%
Net Profit 20 20
7% 7%
12%

In millions CHF.

Don't miss a Thing! We will send you all news about Ivf Hartmann Holding directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

IVF HARTMANN Holding AG engages in the production and distribution of medical consumer products. It operates through the following segments: Wound Management, Incontinence Management, Risk Prevention, Disinfection, Personal Healthcare, and Facility Products. The Wound Management segment provides traditional wound treatment; negative pressure wound therapy; as well as compression and support therapy. The Incontinence Management segment offers securing systems; medicinal skin care; including patient and personal hygiene. The Risk Prevention segment provides disposable surgical instruments, surgical clothing, as well as surgical and examination gloves. The Disinfection segment sells hand disinfection, hand protection, and skin disinfection. The Personal Healthcare segment markets plaster and wound dressings; thermometers; and sphygmomanometers. The Facility Products segment supplies hygienic paper, microfiber wipes, and foils products. The company was founded on April 13, 1883 and is headquartered in Neuhausen, Switzerland.

Head office Switzerland
CEO Dr. Martini
Employees 279
Founded 1883
Website www.ivf.hartmann.info

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today